{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:34:22Z","timestamp":1792276462894,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002767","name":"Department of Science and Technology of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","award":["2024"],"award-info":[{"award-number":["2024"]}],"id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jare.2024.09.009","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T08:50:22Z","timestamp":1726131022000},"page":"391-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Biomarkers differentiating regression from progression among untreated cervical intraepithelial neoplasia grade 2 lesions"],"prefix":"10.1016","volume":"74","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2024.09.009_b0005","unstructured":"Organization WH. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, 2021."},{"issue":"20","key":"10.1016\/j.jare.2024.09.009_b0010","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1001\/jama.2023.21987","article-title":"Cervical cancer screening","volume":"330","author":"Voelker","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.jare.2024.09.009_b0015","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.jare.2024.09.009_b0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048055","article-title":"Natural history of histologically confirmed high-grade cervical intraepithelial neoplasia during pregnancy: meta-analysis","volume":"11","author":"Chen","year":"2021","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.jare.2024.09.009_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2023.08.008","article-title":"Clinical course of cervical intraepithelial neoplasia grade 2: a population-based cohort study","volume":"229","author":"Lycke","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.jare.2024.09.009_b0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/LGT.0000000000000604","article-title":"The natural history of cervical intraepithelial neoplasia grades 1, 2, and 3: a systematic review and meta-analysis","volume":"25","author":"Loopik","year":"2021","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"10.1016\/j.jare.2024.09.009_b0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jare.2024.09.009_b0040","doi-asserted-by":"crossref","unstructured":"Biopsy and selective recall compared with immediate large loop excision in management of women with low grade abnormal cervical cytology referred for colposcopy: multicentre randomised controlled trial. Bmj 2009;339:b2548.","DOI":"10.1136\/bmj.b2548"},{"key":"10.1016\/j.jare.2024.09.009_b0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075925","article-title":"Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort study","volume":"383","author":"Lycke","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jare.2024.09.009_b0050","doi-asserted-by":"crossref","unstructured":"Gori S, Frayle H, Pagan A, et al. Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy. Fam Med Community Health 2024;12(Suppl 2).","DOI":"10.1136\/fmch-2023-002595"},{"issue":"3","key":"10.1016\/j.jare.2024.09.009_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.02.029","article-title":"Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women","volume":"223","author":"Dempster-Rivett","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jare.2024.09.009_b0060","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/AOG.0000000000004705","article-title":"Known benefits and unknown risks of active surveillance of cervical intraepithelial neoplasia grade 2","volume":"139","author":"Lycke","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"9590","key":"10.1016\/j.jare.2024.09.009_b0065","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","article-title":"Human papillomavirus and cervical cancer","volume":"370","author":"Schiffman","year":"2007","journal-title":"Lancet"},{"issue":"9895","key":"10.1016\/j.jare.2024.09.009_b0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2024.09.009_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2023.200258","article-title":"Human papillomavirus genomics: understanding carcinogenicity","volume":"15","author":"Nelson","year":"2023","journal-title":"Tumour Virus Res"},{"key":"10.1016\/j.jare.2024.09.009_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvr.2021.200213","article-title":"Human papillomavirus E6 and E7: what remains?","volume":"11","author":"Vats","year":"2021","journal-title":"Tumour Virus Res"},{"issue":"26","key":"10.1016\/j.jare.2024.09.009_b0085","doi-asserted-by":"crossref","first-page":"10516","DOI":"10.1073\/pnas.1202684109","article-title":"A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer","volume":"109","author":"Herfs","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"10.1016\/j.jare.2024.09.009_b0090","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.jare.2024.09.009_b0095","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.jare.2024.09.009_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogoh.2022.102442","article-title":"Regression of cervical high-grade squamous intraepithelial lesions (HSIL\/CIN2) managed expectantly","volume":"51","author":"Nourrisson","year":"2022","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"3","key":"10.1016\/j.jare.2024.09.009_b0105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ygyno.2021.06.019","article-title":"Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: cytology and HPV genotyping","volume":"162","author":"Salvad\u00f3","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.jare.2024.09.009_b0110","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/ijc.25630","article-title":"Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study","volume":"128","author":"Matsumoto","year":"2011","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.jare.2024.09.009_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2021.09.009","article-title":"Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years","volume":"226","author":"Sykes","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jare.2024.09.009_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2022.06.051","article-title":"Active expectancy as alternative to treatment for cervical intraepithelial neoplasia grade 2 in women aged 25 to 30 years: ExCIN2-a prospective clinical multicenter cohort study","volume":"227","author":"Kyleb\u00e4ck","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jare.2024.09.009_b0125","doi-asserted-by":"crossref","unstructured":"Damgaard R, Jenkins D, Stoler MH, et al. HPV genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2. Am J Obstet Gynecol 2024.","DOI":"10.1016\/j.ajog.2024.01.029"},{"issue":"10","key":"10.1016\/j.jare.2024.09.009_b0130","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.drudis.2019.07.011","article-title":"Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins","volume":"24","author":"Almeida","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jare.2024.09.009_b0135","doi-asserted-by":"crossref","unstructured":"Templeton CW, Laimins LA. p53-dependent R-loop formation and HPV pathogenesis. Proc Natl Acad Sci USA. 2023;120(35):e2305907120.","DOI":"10.1073\/pnas.2305907120"},{"key":"10.1016\/j.jare.2024.09.009_b0140","doi-asserted-by":"crossref","unstructured":"Li Q, Xie B, Chen X, et al. SNORD6 promotes cervical cancer progression by accelerating E6-mediated p53 degradation. Cell Death Discov 2023;9(1):192.","DOI":"10.1038\/s41420-023-01488-w"},{"issue":"10","key":"10.1016\/j.jare.2024.09.009_b0145","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1007\/s00253-020-10492-4","article-title":"HPV16 E7-impaired keratinocyte differentiation leads to tumorigenesis via cell cycle\/pRb\/involucrin\/spectrin\/adducin cascade","volume":"104","author":"Ci","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"10.1016\/j.jare.2024.09.009_b0150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1073\/pnas.0510012103","article-title":"The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.jare.2024.09.009_b0155","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3892\/ol.2020.11711","article-title":"Analysis of factors affecting the prognosis of patients with cervical intraepithelial neoplasia 2","volume":"20","author":"Zhang","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jare.2024.09.009_b0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4137\/BMI.S14296","article-title":"Prognostic value of DNA and mRNA e6\/e7 of human papillomavirus in the evolution of cervical intraepithelial neoplasia grade 2","volume":"9","author":"Discacciati","year":"2014","journal-title":"Biomark Insights"},{"issue":"6","key":"10.1016\/j.jare.2024.09.009_b0165","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ijc.27750","article-title":"Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia","volume":"132","author":"Mirabello","year":"2013","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jare.2024.09.009_b0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.virol.2006.11.010","article-title":"High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia","volume":"361","author":"Turan","year":"2007","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.jare.2024.09.009_b0175","first-page":"2278","article-title":"Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions","volume":"15","author":"Torres-Rojas","year":"2018","journal-title":"Oncol Lett"},{"issue":"9","key":"10.1016\/j.jare.2024.09.009_b0180","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1158\/1078-0432.CCR-17-3251","article-title":"Human papillomavirus DNA methylation as a biomarker for cervical precancer: consistency across 12 genotypes and potential impact on management of HPV-positive women","volume":"24","author":"Clarke","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.jare.2024.09.009_b0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/IGC.0b013e31827da1f6","article-title":"L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia","volume":"23","author":"Oka","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.jare.2024.09.009_b0190","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcv.2013.06.026","article-title":"Methylation of human papillomavirus-52 and -58 is a candidate biomarker in cervical neoplasia","volume":"58","author":"Murakami","year":"2013","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.jare.2024.09.009_b0195","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.jare.2024.09.009_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2009.05.046","article-title":"Value of p16(INK4a) as a marker of progression\/regression in cervical intraepithelial neoplasia grade 1","volume":"201","author":"del Pino","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.jare.2024.09.009_b0205","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00428-004-1127-9","article-title":"p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri","volume":"445","author":"Negri","year":"2004","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.jare.2024.09.009_b0210","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.28485","article-title":"p16INK4A immunohistochemical staining and predictive value for progression of cervical intraepithelial neoplasia grade 1: a prospective study in China","volume":"134","author":"Liao","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.jare.2024.09.009_b0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijgo.2015.12.005","article-title":"The association between p16 and Ki-67 immunohistostaining and the progression of cervical intraepithelial neoplasia grade 2","volume":"134","author":"Miyamoto","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.jare.2024.09.009_b0220","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/modpathol.2016.168","article-title":"Usefulness of p16(INK4a) staining for managing histological high-grade squamous intraepithelial cervical lesions","volume":"30","author":"Miralpeix","year":"2017","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.jare.2024.09.009_b0225","doi-asserted-by":"crossref","DOI":"10.1590\/1516-3180.2022.0527.r2.280423","article-title":"Cervical Intraepithelial Neoplasia grade 2 biopsy: Do p16INK4a and Ki-67 biomarkers contribute to the decision to treat? A cross-sectional study","volume":"142","author":"Ferreira","year":"2023","journal-title":"Sao Paulo Med J"},{"issue":"5","key":"10.1016\/j.jare.2024.09.009_b0230","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1525-1438.2007.00899.x","article-title":"p16(INK4a) expression does not predict the outcome of cervical intraepithelial neoplasia grade 2","volume":"17","author":"Guedes","year":"2007","journal-title":"Int J Gynecol Cancer Sep-Oct"},{"issue":"4","key":"10.1016\/j.jare.2024.09.009_b0235","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00404-020-05853-3","article-title":"Factors predicting the spontaneous regression of cervical high-grade squamous intraepithelial lesions (HSIL\/CIN2)","volume":"303","author":"Brun","year":"2021","journal-title":"Arch Gynecol Obstet"},{"issue":"6","key":"10.1016\/j.jare.2024.09.009_b0240","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/ijgc-2019-000343","article-title":"Prognostic factors for spontaneous regression of high-risk human papillomavirus-positive cervical intra-epithelial neoplasia grade 2","volume":"29","author":"Koeneman","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"10.1016\/j.jare.2024.09.009_b0245","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/cid\/ciz677","article-title":"Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia","volume":"70","author":"Louvanto","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"26","key":"10.1016\/j.jare.2024.09.009_b0250","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1200\/JCO.21.02433","article-title":"Clinical regression of high-grade cervical intraepithelial neoplasia is associated with absence of FAM19A4\/miR124-2 DNA methylation (CONCERVE study)","volume":"40","author":"Kremer","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jare.2024.09.009_b0255","doi-asserted-by":"crossref","unstructured":"Hoyer H, Stolte C, B\u00f6hmer G, et al. Evaluation of CIN2\/3 Lesion Regression in GynTect(\u00ae) DNA Methylation-Marker-Negative Patients in a Longitudinal Study. Cancers (Basel) 3 2023;15(15).","DOI":"10.3390\/cancers15153951"},{"issue":"1","key":"10.1016\/j.jare.2024.09.009_b0260","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15340","article-title":"Association of HLA class I and II genes with cervical cancer susceptibility in a Han Chinese population","volume":"103","author":"Yao","year":"2024","journal-title":"Hla"},{"key":"10.1016\/j.jare.2024.09.009_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101748","article-title":"HLA-DRB1 alleles and cervical cancer: a meta-analysis of 36 case-control studies","volume":"67","author":"Kamiza","year":"2020","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10.1016\/j.jare.2024.09.009_b0270","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/IGC.0b013e3182439500","article-title":"HLA class II DRB1*1302 allele protects against progression to cervical intraepithelial neoplasia grade 3: a multicenter prospective cohort study","volume":"22","author":"Matsumoto","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"10.1016\/j.jare.2024.09.009_b0275","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/cas.12760","article-title":"Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: at which step of multistage carcinogenesis?","volume":"106","author":"Matsumoto","year":"2015","journal-title":"Cancer Sci"},{"issue":"13","key":"10.1016\/j.jare.2024.09.009_b0280","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-04-2599","article-title":"Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype","volume":"11","author":"Trimble","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.jare.2024.09.009_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/v15091953","article-title":"The high-risk human papillomavirus type influences the tissue microenvironment in cervical intraepithelial neoplasia grade 2","volume":"15","author":"Saito","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jare.2024.09.009_b0290","article-title":"HPV-16 E7-specific cellular immune response in women with cervical intraepithelial lesion contributes to viral clearance: a cross-sectional and longitudinal clinical study","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jare.2024.09.009_b0295","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3892\/ol.2015.3295","article-title":"Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer","volume":"10","author":"Song","year":"2015","journal-title":"Oncol Lett"},{"issue":"8","key":"10.1016\/j.jare.2024.09.009_b0300","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1158\/1078-0432.CCR-06-2916","article-title":"HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions","volume":"13","author":"Peng","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.jare.2024.09.009_b0305","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/modpathol.2010.109","article-title":"Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression","volume":"23","author":"\u00d8vestad","year":"2010","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.jare.2024.09.009_b0310","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/jcp.2010.083626","article-title":"The impact of epithelial biomarkers, local immune response and human papillomavirus genotype in the regression of cervical intraepithelial neoplasia grades 2\u20133","volume":"64","author":"Ovestad","year":"2011","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.jare.2024.09.009_b0315","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ygyno.2012.09.010","article-title":"Interaction of epithelial biomarkers, local immune response and condom use in cervical intraepithelial neoplasia 2\u20133 regression","volume":"127","author":"Munk","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.jare.2024.09.009_b0320","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2023.34.e2","article-title":"Evaluation of CD4(+) cells infiltration as a prognostic factor in cervical intraepithelial neoplasia 2","volume":"34","author":"Chen","year":"2023","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.jare.2024.09.009_b0325","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00432-021-03838-6","article-title":"Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia","volume":"148","author":"Vattai","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"10.1016\/j.jare.2024.09.009_b0330","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/ijc.31814","article-title":"Toll-like receptors: Important immune checkpoints in the regression of cervical intra-epithelial neoplasia 2","volume":"143","author":"Halec","year":"2018","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.jare.2024.09.009_b0335","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s00432-022-03993-4","article-title":"Blimp-1 is a prognostic indicator for progression of cervical intraepithelial neoplasia grade 2","volume":"148","author":"Saito","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jare.2024.09.009_b0340","doi-asserted-by":"crossref","unstructured":"Nicol\u00f2 S, Antonelli A, Tanturli M, et al. Bacterial species from vaginal microbiota differently affect the production of the E6 and E7 oncoproteins and of p53 and p-Rb oncosuppressors in HPV16-infected cells. Int J Mol Sci 2023;24(8).","DOI":"10.3390\/ijms24087173"},{"issue":"3","key":"10.1016\/j.jare.2024.09.009_b0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008376","article-title":"Cervicovaginal microbiome and natural history of HPV in a longitudinal study","volume":"16","author":"Usyk","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jare.2024.09.009_b0350","article-title":"Vaginal microbiota changes caused by HPV infection in Chinese women","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jare.2024.09.009_b0355","doi-asserted-by":"crossref","unstructured":"Kang GU, Jung DR, Lee YH, et al. Potential association between vaginal microbiota and cervical carcinogenesis in Korean women: a cohort study. Microorganisms 2021;9(2).","DOI":"10.3390\/microorganisms9020294"},{"issue":"11","key":"10.1016\/j.jare.2024.09.009_b0360","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1002\/jmv.28001","article-title":"Prevotella as the hub of the cervicovaginal microbiota affects the occurrence of persistent human papillomavirus infection and cervical lesions in women of childbearing age via host NF-\u03baB\/C-myc","volume":"94","author":"Dong","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.jare.2024.09.009_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103009","article-title":"Clinical relevance of plasma virome dynamics in liver transplant recipients","volume":"60","author":"Thijssen","year":"2020","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.jare.2024.09.009_b0370","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virs.2022.12.004","article-title":"Altered vaginal eukaryotic virome is associated with different cervical disease status","volume":"38","author":"Li","year":"2023","journal-title":"Virol Sin"},{"key":"10.1016\/j.jare.2024.09.009_b0375","doi-asserted-by":"crossref","unstructured":"Mitra A, MacIntyre DA, Ntritsos G, et al. The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions. Nat Commun 2020;11(1):1999.","DOI":"10.1038\/s41467-020-15856-y"},{"key":"10.1016\/j.jare.2024.09.009_b0380","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2016.09.012","article-title":"A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters","volume":"59","author":"Koeneman","year":"2017","journal-title":"Hum Pathol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209012322400393X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209012322400393X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:51:06Z","timestamp":1762599066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209012322400393X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":76,"alternative-id":["S209012322400393X"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2024.09.009","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers differentiating regression from progression among untreated cervical intraepithelial neoplasia grade 2 lesions","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2024.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}